Engineering Metal‐Organic‐Framework‐Based STING Nanoagonists for PROTAC‐Enhanced Cancer Chemo‐Metalloimmunotherapy
Abstract Chemo‐metalloimmunotherapy is emerging as a promising strategy for cancer treatment by integrating chemotherapy‐induced immunogenicity with metal ion‐mediated immune activation. However, its efficacy is hampered by chemoresistance and immune escape driven by PD‐L1 upregulation. Here, a mult...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2026-01-01
|
| Colección: | Advanced Science |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/advs.202515006 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|